We exposed two wild-type TP53 cell lines, CHP-134 and IMR-32, to GSK2830371 for one hour prior to treatment with doxorubicin or carboplatin, neuroblastoma standard of care induction drugs, for 3 days. Here, TP53 is linked to neuroblastoma.